| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T79 |
0-78 |
Sentence |
denotes |
Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas |
| T1 |
0-78 |
Sentence |
denotes |
Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas |
| T2 |
80-88 |
Sentence |
denotes |
Abstract |
| T80 |
89-251 |
Sentence |
denotes |
Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. |
| T3 |
89-251 |
Sentence |
denotes |
Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. |
| T81 |
252-373 |
Sentence |
denotes |
WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. |
| T4 |
252-373 |
Sentence |
denotes |
WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. |
